Publication Information

{'id': 'https://openalex.org/W3131346849', 'doi': 'https://doi.org/10.1097/01.cot.0000735152.04137.fe', 'title': 'Genetic Mutations Signal Worse Survival in Young Black AML Patients', 'display_name': 'Genetic Mutations Signal Worse Survival in Young Black AML Patients', 'publication_year': 2021, 'publication_date': '2021-02-20', 'ids': {'openalex': 'https://openalex.org/W3131346849', 'doi': 'https://doi.org/10.1097/01.cot.0000735152.04137.fe', 'mag': '3131346849'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.cot.0000735152.04137.fe', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210170078', 'display_name': 'Oncology Times', 'issn_l': '0276-2234', 'issn': ['0276-2234', '1548-4688'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310318547', 'host_organization_name': 'Wolters Kluwer', 'host_organization_lineage': ['https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://doi.org/10.1097/01.cot.0000735152.04137.fe', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5113771729', 'display_name': 'Mark L. Fuerst', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Mark L. Fuerst', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5113771729'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 57}, 'biblio': {'volume': '43', 'issue': 'S4', 'first_page': '9', 'last_page': '9'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9891, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 0.9891, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9566, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7151818}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.71365654}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.58576703}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.558655}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.53805584}, {'id': 'https://openalex.org/C2776601000', 'wikidata': 'https://www.wikidata.org/wiki/Q612108', 'display_name': 'Acute promyelocytic leukemia', 'level': 4, 'score': 0.5165183}, {'id': 'https://openalex.org/C107130276', 'wikidata': 'https://www.wikidata.org/wiki/Q133805', 'display_name': 'Epidemiology', 'level': 2, 'score': 0.5068186}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.478877}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.4742519}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.45121813}, {'id': 'https://openalex.org/C147077947', 'wikidata': 'https://www.wikidata.org/wiki/Q1515895', 'display_name': 'Socioeconomic status', 'level': 3, 'score': 0.4316876}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.41807824}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.15924564}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.12006745}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.11572188}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.106419474}, {'id': 'https://openalex.org/C2781121885', 'wikidata': 'https://www.wikidata.org/wiki/Q425517', 'display_name': 'Retinoic acid', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.cot.0000735152.04137.fe', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210170078', 'display_name': 'Oncology Times', 'issn_l': '0276-2234', 'issn': ['0276-2234', '1548-4688'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310318547', 'host_organization_name': 'Wolters Kluwer', 'host_organization_lineage': ['https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://journals.lww.com/oncology-times/Fulltext/2021/02201/Genetic_Mutations_Signal_Worse_Survival_in_Young.6.aspx', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.cot.0000735152.04137.fe', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210170078', 'display_name': 'Oncology Times', 'issn_l': '0276-2234', 'issn': ['0276-2234', '1548-4688'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310318547', 'host_organization_name': 'Wolters Kluwer', 'host_organization_lineage': ['https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/1', 'score': 0.61, 'display_name': 'No poverty'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4388452973', 'https://openalex.org/W4288206874', 'https://openalex.org/W3143468013', 'https://openalex.org/W3030644525', 'https://openalex.org/W2990397977', 'https://openalex.org/W2914915027', 'https://openalex.org/W2537486978', 'https://openalex.org/W2417600469', 'https://openalex.org/W2364732766', 'https://openalex.org/W1976946639'], 'abstract_inverted_index': {'black': [0, 2], 'patients:': [1], 'patientsYoung': [3], 'Black': [4, 35, 60, 324, 355, 410, 439, 486, 533, 582, 634, 667, 695, 706, 737, 778, 825, 839, 858, 877, 942, 963, 988, 1028, 1058], 'acute': [5, 213], 'myeloid': [6], 'leukemia': [7], '(AML)': [8], 'patients': [9, 39, 62, 73, 118, 234, 265, 297, 311, 326, 358, 412, 425, 441, 487, 498, 525, 707, 720, 859, 992, 1059], 'have': [10, 63, 67, 131, 416], 'poorer': [11], 'overall': [12], 'survival': [13, 58, 308, 352, 379, 575, 599, 820, 875, 1095], '(OS)': [14], 'than': [15, 71, 496], 'younger': [16, 423, 443, 532, 647], 'White': [17, 37, 72, 175, 337, 357, 424, 497, 535, 563, 704, 719, 990], 'AML': [18, 38, 47, 61, 153, 176, 211, 233, 310, 325, 338, 349, 411, 440, 536, 648, 747, 826, 991, 1015], 'patients,': [19, 154, 350, 537, 564, 889], 'according': [20], 'to': [21, 66, 105, 116, 135, 202, 415, 422, 541, 562, 718, 909, 928, 933, 939, 953, 955, 979, 1063, 1090], 'research': [22], 'presented': [23], 'at': [24, 444, 594, 629, 1017], 'the': [25, 114, 187, 196, 278, 304, 321, 351, 405, 445, 476, 516, 598, 622, 675, 756, 759, 767, 810, 830, 861, 890, 895, 905, 913, 967, 996, 999, 1014, 1023, 1038, 1072], '2020': [26], 'ASH': [27], 'Annual': [28], 'Meeting': [29], '(Abstract': [30], '6).': [31], 'Mutational': [32], 'differences': [33, 45, 89, 434, 523, 639, 671, 981, 997], 'between': [34, 216, 259, 354, 395, 531, 986], 'and': [36, 113, 128, 161, 164, 190, 218, 239, 261, 292, 356, 386, 397, 432, 464, 511, 534, 544, 549, 576, 596, 621, 653, 659, 688, 729, 753, 763, 788, 842, 897, 902, 926, 957, 989, 1045, 1053, 1067, 1094], 'might': [40], 'be': [41, 934, 1075], 'an': [42, 54, 147, 267, 740, 845, 919, 935], 'indicator': [43], 'for': [44, 56, 243, 290, 296, 317, 348, 501, 581, 723, 823, 850, 887, 941, 1013, 1057, 1080], 'in': [46, 90, 231, 246, 272, 320, 378, 404, 455, 524, 559, 628, 640, 646, 666, 674, 745, 777, 841, 860, 866, 884, 912, 982, 998, 1083], 'tumor': [48], 'biology': [49, 985], 'that': [50, 99, 335, 485, 736, 818, 837, 873, 922, 946, 961, 1009, 1033, 1048, 1060], 'could': [51, 100, 606], 'potentially': [52], 'provide': [53], 'explanation': [55], 'this': [57, 389, 565, 609], 'disparity.': [59, 610], 'been': [64, 86, 133], 'shown': [65], 'higher': [68, 76, 286, 300, 329, 450, 466, 492, 558, 712, 773], 'mortality': [69], 'rates': [70, 530, 555], 'despite': [74], 'a': [75, 183, 284, 293, 299, 328, 449, 465, 489, 709, 772, 782, 814, 951, 1078, 1087, 1101], 'prevalence': [77], 'of': [78, 149, 151, 158, 169, 174, 195, 228, 288, 309, 331, 336, 368, 447, 452, 468, 494, 506, 509, 513, 589, 617, 624, 633, 643, 677, 714, 761, 775, 800, 813, 816, 832, 843, 856, 863, 876, 899, 1001, 1040], 'favorable-risk': [79], 'cytogenetic': [80, 126, 686], 'risk': [81, 287, 295, 330, 493, 682, 713, 774, 1026, 1065], 'factors.': [82], 'This': [83, 584], 'disparity': [84, 353], 'has': [85, 342, 359], 'associated': [87, 698, 770], 'with': [88, 110, 172, 210, 298, 334, 436, 699, 703, 771, 793], 'treatments': [91, 865], 'received,': [92], 'as': [93, 95, 716, 766, 950, 993, 1027, 1077, 1086], 'well': [94], 'various': [96], 'socioeconomic': [97, 433, 833, 1051], 'factors': [98, 587, 817, 834], 'affect': [101], 'compliance': [102], 'or': [103, 461, 528, 680], 'access': [104], 'tertiary': [106], 'care': [107, 940], 'disease': [108, 604, 984, 1055], 'centers': [109], 'disease-specific': [111], 'expertise': [112], 'infrastructure': [115], 'place': [117], 'on': [119, 236, 251, 462, 685], 'clinical': [120, 867], 'trials.': [121], 'Multiple': [122], 'disease-related': [123], 'factors,': [124], 'including': [125, 155], 'findings': [127, 687], 'gene': [129, 625, 690, 1003], 'mutations,': [130], 'also': [132, 165], 'identified': [134, 758], 'impact': [136, 831, 874, 896], 'patient': [137], 'outcomes.': [138], 'To': [139, 220], 'assess': [140], 'possible': [141, 156, 969], 'race-associated': [142], 'molecular': [143, 167, 222], 'differences,': [144], 'researchers': [145, 224, 757, 891], 'conducted': [146], 'analysis': [148, 483, 616, 734, 911], 'outcomes': [150, 855], 'adult': [152], 'impacts': [157], 'sociodemographic,': [159], 'financial,': [160], 'racial': [162], 'disparities,': [163, 821], 'characterized': [166], 'features': [168, 1012], 'Blacks': [170, 560], 'compared': [171, 333, 421, 561, 702, 717], 'those': [173], 'patients.': [177, 339, 583, 635, 668, 779, 827, 943, 1029], 'Identifying': [178], 'Disparities': [179], 'Abstract': [180], '6': [181], 'For': [182], 'nationwide': [184], 'population': [185, 1016], 'analysis,': [186, 694], 'Surveillance,': [188], 'Epidemiology,': [189], 'End': [191], 'Results': [192], '(SEER)': [193], 'Program': [194], 'National': [197], 'Cancer': [198, 238, 374], 'Institute': [199], 'was': [200, 283, 312, 380, 697, 882], 'used': [201, 1076], 'identify': [203, 956], '25,523': [204], 'adults': [205], 'aged': [206], '18-60': [207], 'years': [208], 'diagnosed': [209], '(excluding': [212], 'promyelocytic': [214], 'leukemia)': [215], '1986': [217, 260, 385], '2015.': [219], 'characterize': [221], 'features,': [223], 'performed': [225, 612], 'targeted': [226, 613], 'sequencing': [227, 615], '81': [229, 618], 'genes': [230, 620, 645, 655], '1,339': [232], 'treated': [235], 'frontline': [237], 'Leukemia': [240], 'Group': [241], 'B/Alliance': [242], 'Clinical': [244], 'Trials': [245], 'Oncology': [247], '(Alliance)': [248], 'protocols': [249], 'based': [250, 684], 'standard': [252], 'intensity': [253], 'cytarabine/anthracycline': [254], 'induction': [255, 542], 'followed': [256], 'by': [257, 995], 'consolidation': [258], '2016.': [262], 'No': [263], 'Alliance': [264, 517], 'received': [266], 'allogeneic': [268], 'stem': [269], 'cell': [270], 'transplant': [271, 881, 914], 'first': [273, 885], 'complete': [274], 'remission': [275, 886], '(CR).': [276], 'In': [277, 515, 692, 751, 803], 'SEER': [279], 'data,': [280, 518], 'while': [281, 835], 'there': [282, 519], 'slightly': [285, 557], 'dying': [289, 332, 495, 526, 715, 776], 'men': [291], 'lower': [294], 'median': [301], 'household': [302], 'income,': [303], 'strongest': [305], 'factor': [306, 744], 'affecting': [307], 'self-reported': [313], 'race,': [314], 'after': [315, 499, 721], 'accounting': [316], 'other': [318, 437, 1084], 'variables': [319], 'model.': [322], 'Specifically,': [323], 'had': [327, 488, 708], '“Although': [340], 'OS': [341, 419, 577, 701], 'actually': [343, 360], 'improved': [344], 'across': [345], '3': [346], 'decades': [347], 'widened,”': [361], 'said': [362, 479, 650, 749, 971], 'lead': [363, 908, 1062], 'author': [364], 'Bhavana': [365], 'Bhatnagar,': [366], 'DO,': [367], 'The': [369, 852], 'Ohio': [370], 'State': [371], 'University': [372], 'Comprehensive': [373], 'Center.': [375], '“The': [376], 'difference': [377, 390, 566, 1056], 'not': [381, 568, 1020], 'statistically': [382], 'significant': [383, 522], 'from': [384, 471, 965], '1995;': [387], 'however,': [388], 'did': [391, 567, 637], 'achieve': [392], 'statistical': [393, 570], 'significance': [394], '1996': [396], '2005.': [398], 'It': [399], 'became': [400], 'even': [401, 1041], 'more': [402, 458, 663], 'noticeable': [403], 'most': [406], 'recent': [407], 'decade.”': [408], 'Younger': [409], 'were': [413, 442, 459, 520, 556, 578, 656, 662, 672], 'found': [414, 627], 'worse': [417, 580, 700], '3-year': [418], '(34%)': [420], '(43%).': [426], '“We': [427, 611, 1030], 'observed': [428], 'some': [429], 'notable': [430], 'demographic': [431], 'consistent': [435], 'studies.': [438], 'time': [446], 'diagnosis,': [448], 'proportion': [451], 'them': [453, 469], 'resided': [454], 'metropolitan': [456, 504], 'areas,': [457], 'uninsured': [460], 'Medicaid,': [463], 'percentage': [467], 'came': [470], 'families': [472], 'who': [473], 'lived': [474], 'below': [475], 'poverty': [477], 'level,”': [478], 'Bhatnagar.': [480, 651, 750, 972], 'A': [481], 'multivariate': [482], 'showed': [484], '27': [490], 'percent': [491, 632, 711], 'adjustment': [500, 722], 'age,': [502, 724], 'sex,': [503], 'area': [505], 'residence,': [507], 'measure': [508], 'poverty,': [510], 'decade': [512], 'diagnosis.': [514], 'no': [521, 670, 880], 'early': [527, 550], 'CR': [529], 'indicating': [538], 'similar': [539, 864, 1081], 'response': [540], 'treatment': [543, 590, 1068], 'likely': [545, 593], 'comparable': [546], 'performance': [547], 'status': [548], 'complication': [551], 'rates.': [552], 'While': [553], 'relapse': [554], 'reach': [569], 'significance.': [571], 'However,': [572], 'both': [573, 1050], 'disease-free': [574], 'significantly': [579], 'suggests': [585, 735], 'additional': [586, 871], 'outside': [588], 'selection': [591], 'are': [592, 790], 'play': [595], 'influencing': [597], 'disparity,': [600], 'she': [601, 797], 'said.': [602, 798], 'Underlying': [603], 'pathology': [605], 'possibly': [607], 'explain': [608], 'next-generation': [614], 'leukemia-associated': [619], 'oncoprint': [623], 'mutations': [626, 661, 765, 769], 'least': [630], '5': [631], 'We': [636, 828, 944, 1070], 'see': [638], 'mutation': [641], 'frequency': [642, 898], 'several': [644], 'patients,”': [649, 748], 'NPM1': [652, 730], 'WT1': [654], 'less': [657], 'common': [658], 'IDH2': [660, 764, 789], 'commonly': [664], 'mutated': [665], 'Notably,': [669], 'seen': [673], 'assignment': [676], 'favorable,': [678], 'intermediate,': [679], 'adverse': [681, 742], 'groups': [683], 'selected': [689], 'mutations.': [691, 1004], 'multivariable': [693, 754], 'race': [696, 738], 'race.': [705], '40': [710], 'white': [725], 'blood': [726], 'count,': [727], 'FLT3-ITD,': [728], 'mutational': [731], 'status.': [732], '“Our': [733, 807], 'represents': [739], 'independent': [741, 846], 'prognostic': [743, 848, 1011, 1025], 'young': [746, 824, 857, 987], 'univariable': [752], 'analyses,': [755], 'presence': [760], 'FLT3-ITD': [762, 787], 'only': [768], '“This': [780], 'is': [781, 918, 923, 931, 1100], 'very': [783], 'important': [784, 920, 937], 'finding': [785], 'since': [786], 'now': [791], 'targetable': [792], 'small': [794], 'molecule': [795], 'inhibitors,”': [796], 'Importance': [799], 'More': [801], 'Studies': [802], 'summary,': [804], 'Bhatnagar': [805], 'said:': [806], 'study': [808, 975], 'demonstrates': [809], 'delicate': [811], 'interplay': [812], 'variety': [815], 'influence': [819], 'particularly': [822], 'confirmed': [829], 'demonstrating': [836], 'being': [838], 'is,': [840], 'itself,': [844], 'poor': [847, 854], 'variable': [849], 'survival.': [851], 'persistently': [853], 'setting': [862], 'trials': [868], 'strongly': [869, 1031], 'suggest': [870, 980, 1008], 'components': [872], 'patients.”': [878], 'As': [879], 'offered': [883], 'these': [888, 1034], 'cannot': [892], 'fully': [893], 'exclude': [894], 'off-protocol': [900], 'transplants,': [901], 'they': [903], 'hope': [904, 945, 1071], 'data': [906, 948, 1007, 1035, 1073], 'will': [907, 1074], 'future': [910], 'setting.': [915], '“Structural': [916], 'racism': [917], 'issue': [921], 'often': [924], 'unaddressed': [925], 'difficult': [927], 'study,': [929], 'but': [930], 'accepted': [932], 'incredibly': [936], 'barrier': [938], 'our': [947, 974, 1006], 'serve': [949], 'call': [952], 'action': [954], 'abrogate': [958], 'societal': [959], 'constructs': [960], 'hinder': [962], 'Americans': [964], 'receiving': [966], 'best': [968], 'care,”': [970], '“Importantly,': [973], 'provides': [976], 'powerful': [977], 'evidence': [978], 'underlying': [983], 'evidenced': [994], 'frequencies': [1000], 'recurrent': [1002], 'Moreover,': [1005], 'established': [1010], 'large': [1018], 'do': [1019], 'necessarily': [1021], 'carry': [1022], 'same': [1024], 'believe': [1032], 'should': [1036], 'spark': [1037], 'initiation': [1039], 'larger': [1042], 'multidisciplinary': [1043], 'retrospective': [1044], 'prospective': [1046], 'studies': [1047, 1082], 'address': [1049], 'disadvantages': [1052], 'biological': [1054], 'may': [1061], 'race-specific': [1064], 'stratification': [1066], 'advances.': [1069], 'springboard': [1079], 'malignancies': [1085], 'large-scale': [1088], 'effort': [1089], 'overcome': [1091], 'racial,': [1092], 'health,': [1093], 'disparities.”': [1096], 'Mark': [1097], 'L.': [1098], 'Fuerst': [1099], 'contributing': [1102], 'writer.': [1103]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3131346849', 'counts_by_year': [], 'updated_date': '2024-12-12T23:32:22.287053', 'created_date': '2021-03-01'}